Prophylactic Photodynamic Therapy to Organ Transplant Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Bispebjerg Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00365521
First received: August 15, 2006
Last updated: May 30, 2008
Last verified: May 2008

August 15, 2006
May 30, 2008
April 2009
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00365521 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prophylactic Photodynamic Therapy to Organ Transplant Patients
Not Provided

To evaluate a possible prophylactic efficacy of photodynamic therapy on the incidence of non-melanoma skin cancer, actinic keratoses, warts and keratoses in recently organ transplanted recipients.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind
Organ Transplants
Procedure: Photodynamic Therapy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
50
Not Provided
Not Provided

Inclusion Criteria:

  • Organ transplant recipients.
  • Age 40 years or older.

Exclusion Criteria:

  • Patients younger than 40 years and older than 70 years.
  • Clinical signs of skin cancer, actinic keratoses or warts at the time of inclusion.
  • Previous photodynamic therapy to the skin areas investigated.
  • Pregnancy or breast feeding patients.
  • Patients with porphyria.
  • Patients with a tendency to produce hypertrophic scars or keloids.
  • Patients with known allergy to Metvix.
  • Patients who are not considered able to follow the treatment protocol (e.g. severely alcoholic patients, dementia patients, mentally ill patients etc.).
Both
40 Years to 70 Years
No
Contact: Merete Hædersdal, MD, PhD, DrMedSci +45 35316002 mhaedersdal@dadlnet.dk
Denmark
 
NCT00365521
KF-01-314759
Not Provided
Not Provided
Bispebjerg Hospital
Not Provided
Principal Investigator: Merete Hædersdal, MD, PhD, DrMedSci Bispebjerg Hospital
Bispebjerg Hospital
May 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP